Table 1.
Description of outcome and predictor variables used in the study.
Table 2.
Exogenous Switching Treatment Effects Regression (ESTER) methodology.
Table 3.
Distribution of study participants (6–59 months) with each explanatory variable.
Fig 1.
Prevalence of anthropometric failure in study participants (6–59 months) from NFHS 2015–16 and 2019–21 with selected SES indicators.
Table 4.
Odds ratio and robust standard errors for anthropometric failures in study participants (6–59 months) for NFHS (2015–16).
Table 5.
Odds ratio and robust standard errors for anthropometric failures in study participants (6–59 months) for NFHS (2019–21).
Fig 2.
Marginal effects for anthropometric failures in study participants from logistic regression with interaction between ethnicity/case and wealth index.
Fig 3.
Marginal effects for anthropometric failures in study participants from logistic regression with interaction between ethnicity/caste and education level of the mother.
Fig 4.
Marginal effects for anthropometric failures in study participants from logistic regression with interaction between ethnicity/caste and geographical location of the household.
Table 6.
Exogenous switching treatment effect regression (ESTER) for stunting prevalence in study participants from NFHS 2015–16 and NFHS 2019–21.
Table 7.
Exogenous switching treatment effect regression (ESTER) for wasting prevalence in study participants from NFHS 2015–16 and 2019–21.
Table 8.
Exogenous switching treatment effect regression (ESTER) for underweight prevalence in study participants from NFHS 2015–16 and 2019–21.
Table 9.
Exogenous switching treatment effect regression (ESTER) for overweight prevalence in study participants from NFHS 2015–16 and 2019–21.
Table 10.
Anthropometric failure difference in study participants between ethnic groups using Blinder Oaxaca model for NFHS 2015–16.
Table 11.
Anthropometric failure difference in study participants between ethnic groups using Blinder Oaxaca model for NFHS 2019–21.